ArticleColorectal cancer2025
Surveillance of colorectal neoplasia: a review of guidelines, current evidence, and future directions.
Article in Colorectal cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
About one third of individuals undergoing colonoscopy for colorectal cancer (CRC) screening are found to have neoplasms that require ongoing colonoscopic surveillance for metachronous neoplasia. Current guidelines for post-polypectomy surveillance interval are based on polyp features of size, histology, and multiplicity. Recent large, observational cohort studies delineate CRC risk among individuals with previous neoplasia while others investigate the role of incorporating patient and endoscopist characteristics in addition to polyp features to more precisely identify patients most likely to benefit from surveillance. Several gaps in colorectal neoplasia surveillance remain, including the role of noninvasive stool-based tests and surveillance cessation approaches for older adults. The purpose of this narrative review is to summarize current post-polypectomy surveillance guidelines from around the world, describe recent observational cohort studies quantifying post-polypectomy CRC risk, highlight novel approaches to risk-stratification for surveillance, summarize ongoing clinical trials of surveillance modalities and intervals that will impact practice, and outline an agenda for future research to further improve the efficiency and effectiveness of colorectal neoplasia surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.